The flexibility of the messenger RNA platform means that within about 100 days of any mutation, we can have a vaccine reformulated and on the market ready for vaccination into people. That's a lot quicker than a traditional vaccines platform.
With Moderna working on combined flu and Covid shots, he says, the Department of Health can come to us and request a specific UK mix for UK patients. We can combine a lot of messenger RNAs together so that you can make it very simple for the NHS to deliver.
[
Collection
]
[
|
...
]